ELABHealthcare · Biotechnology

ELAB Stock Forecast: PMGC Holdings, Inc. Price Predictions for 2026-2027

Last close, 3 Aug 2026

$0.91

−1.19% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 3 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap

$4.2M

Ticker Nerd rank

3 / 100

Median analyst target

—

Analysts covering

—

Total return, dividends reinvested

−0.9%

−22.7%

YTD

−97.4%

−99.4%

From 52W high

−99.6%

From 52W low

+3.6%

$217

52-week range, adjusted closes · the dot is the last close

Ticker Nerd rank

ELAB stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores PMGC Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026

3 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Accruals

Revisions

Momentum

Growth

Issuance

Volatility

Quality

Value

Size (97): Smaller than most of the companies we track.

Value (0): The shares cost a lot relative to the profits and assets behind them.

The rank is the raw material. Whether the rules would actually own PMGC Holdings, Inc. — and when they’d sell — is the membership.

Wall Street

ELAB stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ELAB, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

ELAB analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

PMGC Holdings, Inc. (ELAB) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: 0.0×
Price / sales: 3.3×
Price / book: 0.1×
EV / EBITDA: 0.3×

Growth & margins

Revenue growth (YoY): 124.2%
Earnings growth (YoY): —
Gross margin: 33.8%
Operating margin: −484.7%
Net margin: 31.4%

Returns & dividend

Return on equity: −107.9%
Return on assets: −33.3%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

ELAB vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology

Company	Market cap	TKN rank
ELABPMGC Holdings, Inc.	$4.2M	3
MBIOMustang Bio, Inc.	$4.1M	19
SPRCSciSparc Ltd.	$4.0M	24
MTNBMatinas BioPharma Holdings, Inc.	$4.0M	52
FBLGFibroBiologics, Inc.	$4.3M	25
ERNAErnexa Therapeutics, Inc.	$3.8M	25
XRTXXORTX Therapeutics, Inc.	$3.8M	22

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ELAB appears on the weeks it earns a place.

News

Latest ELAB news & analysis

PMGC Holdings Confirms Compliance with Nasdaq's New $5 Million Market Value of Listed Securities Requirement

GlobeNewsWire · 29 July 2026positive

PMGC Holdings announced it has met Nasdaq's $5 million market value of listed securities requirement, reporting 8,095,835 shares of common stock issued and outstanding as of July 29, 2026. The company is also working to correct third-party market data that understates its current share count and market capitalization.

Why it matters — For ELAB watchers, this confirms the company's continued compliance with Nasdaq listing requirements and addresses potential market-data inaccuracies that could affect perceived valuation.

PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc.

GlobeNewsWire · 28 July 2026positive

PMGC Holdings Inc. announced a strategic investment in Precision Aerospace & Defense Group and a long-term aerospace and defense manufacturing agreement through its subsidiary A&B Aerospace Inc.

Why it matters — The investment and long-term agreement expand PMGC Holdings' footprint in the aerospace and defense manufacturing sector, a new strategic direction for the company.

NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to License

GlobeNewsWire · 27 July 2026neutral

NorthStrive Defense Tech has engaged defense software and security firm Deploy360 to validate its patented GPS-denied drone navigation technology, which is under an option to license.

Why it matters — ELAB watchers would care because this news concerns a technology validation engagement by a defense tech firm, which could indicate progress in drone navigation capabilities that may relate to PMGC Holdings' broader strategic interests.

FAQ

Frequently asked questions about ELAB stock

How does Ticker Nerd's model rank ELAB?

As at 1 Aug 2026, PMGC Holdings, Inc. ranks 3 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (97 of 100).

What is the ELAB stock forecast for 2030?

No analyst covering PMGC Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ELAB are extrapolating price history, which says nothing about the business.

How has ELAB stock performed over the past year?

PMGC Holdings, Inc. returned -99.4% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does PMGC Holdings, Inc. do?

PMGC Holdings Inc. is a diversified public holding company based in Newport Beach, California, founded in 2020.

What is the latest news on ELAB?

The most recent item we track (GlobeNewsWire, 29 July 2026): "PMGC Holdings Confirms Compliance with Nasdaq's New $5 Million Market Value of Listed Securities Requirement". PMGC Holdings announced it has met Nasdaq's $5 million market value of listed securities requirement, reporting 8,095,835 shares of common stock issued and outstanding as of July 29, 2026. The company is also working to correct third-party market data that understates its current share count and market capitalization.

Company

About PMGC Holdings, Inc.

PMGC Holdings Inc. is a diversified public holding company based in Newport Beach, California, founded in 2020. The company focuses on acquiring and operating cash-flowing businesses primarily in the manufacturing sector, including IT packaging, CNC machining, mold manufacturing, and specialty metals operations serving aerospace, defense, and industrial markets. It maintains involvement in biopharmaceutical development through subsidiaries like Elevai Biosciences, which advances therapeutic products such as EL-22, an engineered probiotic designed to preserve muscle mass during weight loss treatments including GLP-1 receptor agonists. PMGC Holdings Inc. also engages in medical scientific research and operates investment firms. By divesting non-core assets like skincare operations, the company strengthens its balance sheet while pursuing strategic acquisitions to foster long-term value in high-demand industrial and healthcare innovation segments.

CEO Mr. Graydon Bensler C.F.A. · 32 employees · United States · https://pmgcholdings.com